Today news
About the same in other media
Walmsley needs a fast-acting remedy for GSK’s malaise
Reading now: 247
Few companies fit with the national zeitgeist quite like drugs giant GlaxoSmithKline. But few face the cocktail of pressures Dame Emma Walmsley, chief executive at Britain’s second-biggest drugmaker, is wrestling with. In post since 2017, she is under immense pressure from one of the most aggressive investors on the planet, New York-based hedge fund Elliott Management – famous for chasing Argentina over its sovereign debts for more than decade.
GSK, known for products ranging from HIV treatments to toothpaste, recently won plaudits when itsmalaria vaccine was approved by the World Health Organization. Chancellor Rishi Sunak boasted at the Tory party conference this month about building the UK into a “science superpower”. That vision depends
Read more on theguardian.comAbout this in other media
Cardano needs to break this resistance to ensure recovery and surge ahead ambcrypto.com /3 years ago
ESG oriented blockchain wants on-chain ‘nutrition labels’ for every commodity exchanged cointelegraph.com /3 years ago
Metaverse: Five Things to Know – and What It Could Mean For You cryptonews.com /3 years ago
Show more
The website finance-news.co. is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
